Page last updated: 2024-09-02
ta 0910 and ketanserin
ta 0910 has been researched along with ketanserin in 1 studies
Compound Research Comparison
| Studies (ta 0910) | Trials (ta 0910) | Recent Studies (post-2010) (ta 0910) | Studies (ketanserin) | Trials (ketanserin) | Recent Studies (post-2010) (ketanserin) |
|---|---|---|---|---|---|
| 64 | 2 | 14 | 3,094 | 335 | 283 |
Protein Interaction Comparison
| Protein | Taxonomy | ta 0910 (IC50) | ketanserin (IC50) |
|---|---|---|---|
| 5-hydroxytryptamine receptor 2C | Rattus norvegicus (Norway rat) | 0.0016 | |
| 5-hydroxytryptamine receptor 2A | Rattus norvegicus (Norway rat) | 0.0021 | |
| Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 0.015 | |
| Alpha-1D adrenergic receptor | Rattus norvegicus (Norway rat) | 0.015 | |
| 5-hydroxytryptamine receptor 1D | Homo sapiens (human) | 0.265 | |
| 5-hydroxytryptamine receptor 1B | Homo sapiens (human) | 6.5 | |
| 5-hydroxytryptamine receptor 2A | Homo sapiens (human) | 0.0184 | |
| 5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 0.0027 | |
| 5-hydroxytryptamine receptor 2B | Rattus norvegicus (Norway rat) | 0.0016 | |
| 5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 0.29 | |
| Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 0.015 | |
| D(2) dopamine receptor | Rattus norvegicus (Norway rat) | 1.8 | |
| Synaptic vesicular amine transporter | Homo sapiens (human) | 0.18 | |
| Sigma non-opioid intracellular receptor 1 | Homo sapiens (human) | 0.001 |
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Honda, M; Ono, H; Ono, K; Takasu, K; Tanabe, M; Tokuda, Y | 1 |
Other Studies
1 other study(ies) available for ta 0910 and ketanserin
| Article | Year |
|---|---|
The synthetic TRH analogue taltirelin exerts modality-specific antinociceptive effects via distinct descending monoaminergic systems.
Topics: Adrenergic alpha-Antagonists; Analgesics; Animals; Biogenic Monoamines; Dose-Response Relationship, Drug; Fenclonine; Hot Temperature; Injections, Intraventricular; Injections, Spinal; Injections, Subcutaneous; Ketanserin; Male; Mice; Mice, Inbred ICR; Naloxone; Narcotic Antagonists; Neural Pathways; Norepinephrine; Oxidopamine; Pain Measurement; Physical Stimulation; Reaction Time; Serotonin; Serotonin Agents; Sympatholytics; Thyrotropin; Thyrotropin-Releasing Hormone; Yohimbine | 2007 |